The successful clinical application of immune checkpoint blockade (ICB) and chimeric
antigen receptor T cells (CAR-T) therapeutics has attracted extensive attention to …

Insufficient immune stimulation and stubborn immune resistance are the critical factors
limiting tumor immunotherapy. Here, we report a multifunctional nanoprodrug platform with …

Cancer is the leading cause of death globally, and conventional treatments have limited
efficacy with severe side effects. The use of nanotechnology has the potential to reduce the …

Carbon-based nanomaterials are viewed as preferred candidates as photothermal agents in
tumor photothermal therapy due to their tailored structure and excellent biocompatibility …

In this study, we developed NIR-light responsive poly (lactic-co-glycolic acid)(PLGA)
nanoparticles (NPs) by incorporating the ICG dye for the local delivery of small-molecule …

The cGAS-STING pathway holds tremendous potential as a regulator of immune responses,
offering a means to reshape the tumor microenvironment and enhance tumor …

Tumor residue and tissue damage normally occurred after surgical treatment of malignant
melanoma, and the effective postoperative therapy is still a challenge because the treatment …

Bone metastases severely threaten the lives of patients. Although surgical treatment
combined with adjuvant chemotherapy significantly improves the survival rate of patients …

Nanodendrite particles (NDs) with densely branched structures and biomimetic architectures
have exhibited great promise in tumor therapy owing to their prolonged in vivo circulation …

Surface molecularly imprinted polymers (MIPs) are an efficient and rapidly advancing
approach, increasingly being utilized in drug delivery systems (DDSs). This research …